Production and characterization of monoclonal antibodies against horse immunoglobulins useful for the diagnosis of equine diseases.

This research article discusses the production and characterization of monoclonal antibodies against horse immunoglobulins to aid in the diagnosis of diseases in horses.

Production of Monoclonal Antibodies

• The process of creating monoclonal antibodies (MAbs) against horse immunoglobulins involves immunizing Balb/c mice.
• The researchers immunized these mice using purified horse immunoglobulins.
• The goal of this procedure is to help the mice generate an adaptive immune response, leading to the production of MAbs that directly target the horse immunoglobulins.

Characterizing the Monoclonal Antibodies

• Once these MAbs are generated, the study aimed to characterize them — understanding their specificity and effectiveness
• This characterization was performed in an indirect ELISA versus purified immunoglobulins from several animal species including donkey, cow, buffalo, sheep, pig, and chicken.
• Three particular monoclonal antibodies—1B10B6C9, 1B10B6C10, 1B10B6E9—were found to react only with horse and donkey immunoglobulins (IgG and IgM).
• These monoclonal antibodies were shown to be specific for the Fc fragment of equine IgG when tested with a western blot experiment.

Application of Monoclonal Antibodies in Disease Diagnosis

• One of the monoclonal antibodies, 1B10B6E9, was tested for its usefulness in diagnosing horse diseases.
• It was utilized in a chemiluminescent immunoblotting assay for diagnosing dourine, a sexually transmitted disease in horses.
• This monoclonal antibody was also used in an indirect immunofluorescence assay (IFA) for diagnosing both African horse sickness and dourine.
• The efficacy of these diagnostic methods could lead to improved detection and treatment of such diseases in horses.